These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15576292)

  • 41. High resolution accurate mass screening of prohibited substances in equine plasma using liquid chromatography--Orbitrap mass spectrometry.
    Ho EN; Kwok WH; Wong AS; Wan TS
    Drug Test Anal; 2013 Jul; 5(7):509-28. PubMed ID: 22941912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening].
    Li XW; Shen BH; Zhuo XY
    Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays.
    Marquet P
    Methods Mol Biol; 2012; 902():15-27. PubMed ID: 22767104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current role of LC-MS(/MS) in doping control.
    Thevis M; Thomas A; Schänzer W
    Anal Bioanal Chem; 2011 Aug; 401(2):405-20. PubMed ID: 21424519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control.
    Maurer HH
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):3-25. PubMed ID: 10572972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes.
    Mazzarino M; Cesarei L; de la Torre X; Fiacco I; Robach P; Botrè F
    J Pharm Biomed Anal; 2016 Jan; 117():47-60. PubMed ID: 26342446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemical derivatization for forensic drug analysis by GC- and LC-MS.
    Lin DL; Wang SM; Wu CH; Chen BG; Liu RH
    Forensic Sci Rev; 2016 Jan; 28(1):17-35. PubMed ID: 26841721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioanalytical procedures for determination of drugs of abuse in blood.
    Kraemer T; Paul LD
    Anal Bioanal Chem; 2007 Aug; 388(7):1415-35. PubMed ID: 17468860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening.
    Lynch KL; Breaud AR; Vandenberghe H; Wu AH; Clarke W
    Clin Chim Acta; 2010 Oct; 411(19-20):1474-81. PubMed ID: 20540936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry.
    Thieme D; Sachs H; Uhl M
    Drug Test Anal; 2014; 6(1-2):112-8. PubMed ID: 24424857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening of multiple drugs of abuse and metabolites in urine using LC/MS/MS with polarity switching electrospray ionization.
    Shin M; Ji D; Kang S; Yang W; Choi H; Lee S
    Arch Pharm Res; 2014 Jun; 37(6):760-72. PubMed ID: 23918650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of gas chromatography-mass spectrometry with negative ion chemical ionization in clinical and forensic toxicology, doping control, and biomonitoring.
    Maurer HH
    Ther Drug Monit; 2002 Apr; 24(2):247-54. PubMed ID: 11897971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites.
    Strano-Rossi S; Colamonici C; Botrè F
    Rapid Commun Mass Spectrom; 2007; 21(2):79-88. PubMed ID: 17154357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
    Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
    J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
    Görgens C; Guddat S; Orlovius AK; Sigmund G; Thomas A; Thevis M; Schänzer W
    Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Tauvel FX; Kraemer T
    J Anal Toxicol; 2001; 25(4):237-44. PubMed ID: 11386636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.